- Home
- QURE vs ASA Comparison
QURE vs ASA Comparison
Compare QURE & ASA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QURE | ASA |
|---|---|---|
| Founded | 1998 | 1958 |
| Country | Netherlands | United States |
| Employees | 248 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2013 | 2003 |
Fundamental Metrics
Financial Performance| Metric | QURE | ASA |
|---|---|---|
| Price | $47.51 | $53.35 |
| Analyst Decision | Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $45.00 | N/A |
| AVG Volume (30 Days) | ★ 2.6M | 93.2K |
| Earning Date | 05-05-2026 | 06-01-2026 |
| Dividend Yield | N/A | ★ 0.10% |
| EPS Growth | ★ 29.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,107,000.00 | N/A |
| Revenue This Year | $126.12 | N/A |
| Revenue Next Year | $200.43 | N/A |
| P/E Ratio | ★ N/A | $1.96 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $30.35 |
| 52 Week High | $71.50 | $83.20 |
Technical Indicators
Market Signals| Indicator | QURE | ASA |
|---|---|---|
| Relative Strength Index (RSI) | 73.18 | 38.62 |
| Support Level | $21.63 | $52.98 |
| Resistance Level | $60.70 | $64.43 |
| Average True Range (ATR) | 2.85 | 3.01 |
| MACD | 1.76 | -0.30 |
| Stochastic Oscillator | 87.87 | 16.77 |
Price Performance
Historical ComparisonAbout QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
About ASA ASA Gold and Precious Metals Limited
ASA Gold And Precious Metals Ltd is a closed-end, non-diversified investment company. Its objective is to provide long-term capital appreciation through investing in companies engaged in the exploration for, development of projects, or mining of precious metals and minerals.